Correlation between HIV viral load and aminotransferases as liver damage markers in HIV infected naive patients: A concordance cross-sectional study

Virology Journal

Volumn 6, Issue , 2009, Pages

  Mata Marín, José Antonio ^a   Gaytán Martínez, Jesús ^a   Grados Chavarría, Bernardo Horacio ^b   Fuentes Allen, José Luis ^a   Arroyo Anduiza, Carla Ileana ^a   Alfaro Mejía, Alfredo ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LEUKOCYTE COUNT; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD; BLOOD; ENZYMOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER; LIVER DISEASE; MIDDLE AGED; PATHOLOGY; STATISTICS;

HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; STATISTICS AS TOPIC; VIRAL LOAD; YOUNG ADULT;

EID: 72849139931     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-181     Document Type: Article

References (20)

1. Twenty-five years of HIV/AIDS. AS Fauci, Science 2006 313 409 10.1126/science.1131993 16873613
2. The impact of AIDS on adult mortality: evidence from national and regional statistics. J Blacker, AIDS 2004 18 supl 2 19 S26 10.1097/00002030- 200406002-00003
3. UNAIDS: 2006 AIDS Epidemic update: Geneva (Seitzerland): Joint United Nations Programme on HIV/AIDS, November 2006. http://www.unaids.org
4. Drug-induced liver injury associated with HIV medications. MK Jain, Clin Liver Dis 2007 11 615 39 10.1016/j.cld.2007.06.008 17723923
5. Antiretroviral therapy induced liver alterations. UA Walker, Curr Opin HIV AIDS 2007 2 293 8 10.1097/COH.0b013e328122dbaa 19372901
6. Hepatotoxicity and liver disease in the context of HIV therapy. M Vogel J Rockstroh, Curr Opin HIV AIDS 2007 2 306 13 10.1097/COH.0b013e3281ca6fd2 19372904
7. Reasons for stopping antiretroviral regimen: Increased incidente of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection. A Mocroft AN Phillips V Soriano B Ledergerber O Kirk E Vinogradova P Reiss C Katlama AN Phillips JD Lundgren EuroSIDA Study Group, AIDS Res Hum Retroviruses 2005 21 743 52 10.1089/aid.2005.21.743 16218797
8. HIV antiretroviral medications and hepatotoxicity. Curtis L Cooper, Curr Opin HIV AIDS 2007 2 466 73 10.1097/COH.0b013e3282f0dd0b 19372929
9. HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms. S Pol P Lebray A Vallet-Pichard, Clin Infect Dis 2004 38 suppl 2 65 S72 10.1086/381499 14986277
10. Changes in mitocondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. HC Cote ZL Brumme KJ Craib CS Alexander B Wynhoven L Ting H Wong M Harris PR Harrigan MV O'Shaughnessy JS Montaner, N Engl J Med 2002 346 811 20 10.1056/NEJMoa012035 11893792
11. Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. O Miro S Lápez E Martínez E Pedrol A Milinkovic E Deig G Garrabou J Casademont JM Gatell F Cardellach, Clin Infect Dis 2004 39 710 6 10.1086/423176 15356787
12. Infection with HIV-1 induces a decrease in mt-DNA. M Casula I Bosboom-Dobbelaer K Smolders S Otto M Bakker MP de Baar P Reiss A de Ronde, J Infect Dis 2005 191 1468 71 10.1086/429412 15809905
13. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. E Jacotot L Ravagnan M Loeffler KF Ferri HL Vieira N Zamzami P Costantini S Druillennec J Hoebeke JP Briand T Irinopoulou E Daugas SA Susin D Cointe ZH Xie JC Reed BP Roques G Kroemer, J Exp Med 2000 191 33 46 10620603 10.1084/jem.191.1.33 (Pubitemid 30043646)
14. Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV. A Balasubramanian M Koziel JE Groopman RK Ganju, Clin Infect Dis 2005 41 Supl 1 32 S37 10.1086/429493 (Pubitemid 40863722)
15. Enforced dimerization of Bax results in its translocation, mitochondrial dysfunction and apoptosis. A Gross J Jockel MC Wei SJ Korsmeyer, EMBO J 1998 17 3878 85 9670005 10.1093/emboj/17.14.3878 (Pubitemid 28333974)
16. Nonalcoholic fatty liver disease in HIV infected-patients referred to a metabolic clinic: prevalence, characteristics, and predictors. G Guaraldi N Squillace C Stentarelli G Orlando R D'Amico G Ligabue F Fiocchi S Zona P Loria R Esposito F Palella, Clin Infect Dis 2008 47 250 7 10.1086/589294 18532884
17. Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression. B Zechini Z Pasquazzi A Aceti, Eur J Gastroenterol Hepatol 2004 16 891 6 10.1097/00042737-200409000-00013 15316414
18. Pattern of abnormal liver enzymes in HIV patients presenting al a Nigerian Tertiary Hospital. AA Ejilemele Ca Nwauche OA Ejele, Níger Postgrad Med J 2007 14 306 9
19. Pathogenesis of liver damage in HCV-HIV patients. R Bruno P Sacchi M Puoti L Maiocchi SF Patruno S Cima G Filice, AIDS Rev 2008 10 15 24 18385777
20. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. M Sulkowski S Mehta M Torbenson NH Afdhal L Mirel RD Moore DL Thomas, AIDS 2005 19 585 92 10.1097/01.aids.0000163935.99401. 25 15802977